Trials / Completed
CompletedNCT01840280
A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer
Open, Multicenter Observational Study of Irinotecan Utilized in Mono- or Combination Therapy for the Treatment of Advanced Colorectal Carcinoma.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 324 (actual)
- Sponsor
- Onkovis GmbH · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The main purpose of this observational study with Irinotecan onkovis is to determine the number of treatment cycles and the quantity of Irinotecan onkovis needed for this purpose under the special circumstances of ambulant chemotherapy. Onkovis aims to contribute to an economical utilization of the chemotherapeutics. This includes provision of appropriate packaging sizes to decrease the excess quantity to be discarded, and thus also follows this objective. Secondary objective is the assessment of the side effects of Irinotecan onkovis. To this end, data regarding co-medication and adverse events are also collected.
Conditions
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
- First posted
- 2013-04-25
- Last updated
- 2018-05-23
Locations
5 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01840280. Inclusion in this directory is not an endorsement.